How Early Can Checkpoint Inhibitors Induce a Complete Metabolic Response in Chemorefractory Hodgkin Lymphoma?

enthalten in: Clinical nuclear medicine | 2024

von Georgopoulou, A. | Zerzi, C. | Samaras, V. | +2

A rare case of TEMPI syndrome (telangiectasias, erythrocytosis, monoclonal gammopathy and ascites) associated with IgM monoclonal gammopathy

enthalten in: Leukemia & lymphoma | 2024

von Asimakopoulou, S. | Malandrakis, P. | Kamiliou, A. | +10